date:Feb 25, 2020
Dutch company Royal DSM has agreed to acquire the global human milk oligosaccharides (HMO) supplier Glycom for 765 ($827m).
Established in 2005, Glycom is involved in the development and commercialisation of HMOs for Early Life Nutrition applications.
HMOs offer a collection of carbohydrate structures found in human breast milk. They are essential for both immune and cognitive development.
Royal DSM co-CEOs Geraldine Matchett and Dimitri de Vreeze said: We are looking forward to welcoming Gl